1. Warp Drive Bio Appoints Rachel K. King to Its Board of Directors

    Warp Drive Bio Appoints Rachel K. King to Its Board of Directors

    Warp Drive Bio , a life sciences company developing therapeutics that exploit the molecules and mechanisms of nature, announced today that Rachel K. King will join the company’s board of directors. Ms. King brings to Warp Drive Bio over 25 years of biotechnology leadership experience ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Quotes

    1. Rachel has led the growth of GlycoMimetics from inception to a publicly-traded company with products in late-stage clinical development.
    2. By exploiting the untapped power of medicines that exist in nature, Warp Drive Bio is a pioneer in developing natural products that show enormous potential for patients.
  3. Topics Mentioned